#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Experience with hepatoblastoma treatment in small children – the use of preoperative 3D virtual analysis MeVis for liver resections


Authors: J. Janek 1;  P. Bician 2;  P. Kenderessy 3;  P. Kothaj 1;  K. Novotná 4;  J. Koňarčík 5;  Ľ. Laca 6;  J. Ulianko 1;  I. Dedinská 6
Authors‘ workplace: Chirurgická klinika SZU, FNsP F. D. Roosevelta, Banská Bystrica prednosta: prof. MUDr. P. Kothaj, CSc 1;  Klinika pediatrickej onkológie a hematológie SZU, DFN Banská Bystrica prednosta: MUDr. E. Bubanská, PhD 2;  The Harley Street Clinic, Children’s Hospital, London clinical lead: Dr. D. Inwald, MB BChir MRCP FRCPCH PhD 3;  Rádiologické oddelenie, FNsP F. D. Roosevelta, Banská Bystrica primár: MUDr. S. Okapec 4;  Martinské bioptické centrum s. r. o. vedúci pracoviska: Prof. MUDr. L. Plank, CSc 5;  Chirurgická klinika a transplantačné centrum, FN Martin prednosta: prof. MUDr. L. Laca, PhD 6
Published in: Rozhl. Chir., 2017, roč. 96, č. 1, s. 25-33.
Category: Original articles

Overview

Introduction:
Hepatoblastoma is an uncommon but most frequent liver cancer in infants and children. The therapy is complex, including neoadjuvant, surgical, and adjuvant therapy. For surgery, the presence of a specialized surgeon and an anaesthesiologist is required. For planning the surgery, the 3D analysis MeVis is currently available. The objective of the work is the assessment of a group of children operated for a liver hepatoblastoma and the assessment of contribution of a pre-surgery virtual 3D analysis MeVis for a surgeon.

Methods:
It represents a retrospective assessment of the operated children for the given diagnosis. Upon confirming the disease, the patients underwent neoadjuvant therapy, and then the MeVis analysis of a liver, a surgery, and an adjuvant therapy. The oncologic treatment was performed according to the SIOPEL recommendations.

Results:
In the period of 2012 to 2016, we treated 5 infant patients with the diagnosed hepatoblastoma. The children were at the age between 4 and 37 months, 4 girls, 1 boy. The size of tumours according to the SIOPEL classification was PRETEXT II to IV. All children underwent a surgery without any complications and without any signs of post-operative failure of the post-resection remnant of the liver. The functional volume of the post-resection remnant of the liver was between 28%−70% according to the MeVis analysis. During the long-term monitoring, one patient underwent lung metastasectomy, all children are currently without any signs of relapse of the disease.

Conclusion:
In case of quick catching and correct management of a hepatoblastoma, the results of therapy are very good. For successful treatment, a surgeon experienced in liver resection, presence of a specialized paediatric anaesthesiologist, and a paediatric oncologist are is required. The exact volumetric analysis MeVis is a contribution for a pre-operational review of the finding, and for the preparation of the surgery. The disease is uncommon, and therefore, the groups of patients are small. Due to that reason, the treatment should be centralized to a specialized department.

Key words:
hepatoblastoma − MeVis − volumetry − liver resection


Sources

1. Mikesková M, Kaiserová E. Nádory pečene u detí - prehľad a liečba. Onkológia 2009;4:19−20,22−4.

2. Darbari A, Sabin KM, Shapiro CN, et al. Epidemiology of primary hepatic malignancies in U.S. children. Hepatology 2003;38:560−6.

3. Giardiello FM, Petersen GM, Brensinger JD, et al. Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut 1996;39:867−9.

4. Hartley AL, Birch JM, Kelsey AM, et al. Epidemiological and familial aspects of hepatoblastoma. Med Pediatr Oncol 1990;18:103−9.

5. Taat F, Bosman DK, Aronson DC, et al. Hepatoblastoma in a girl with biliary atresia: coincidence or co-incidence. Pediatr Blood Cancer 2004;43:603−5.

6. Šípek J, Mališ J, Štěrba J, et al. Nádorová onemocnění u dětí s vrozenou vadou. Aktuální data v České republice. Čes Gynekol 2009;74:105−17.

7. Ohama K, Nagase H, Ogino K, et al. Alpha-fetoprotein (AFP) levels in normal children. Eur J Pediatr Surg 1997;7:267−9.

8. Aronson DC, Czauderna P, Maibach R, et al. The treatment of hepatoblastoma: its evolution and the current status as per the SIOPEL trials. J Indian Assoc Pediatr Surg 2014;19:201−17.

9. Roebuck DJ, Aronson D, Clayput P, et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 2007;37:123−32.

10. Aronson DC, Schnater JM, Staalman CR, et al. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol 2005;23:1245−52.

11. Superina RA, Bambini D, Filler RM, et al. A new technique for resecting ´unresectable´ liver tumors. J Pediatr Surg 2000;35:1294−9.

12. La Quaglia MP, Shorter NA, Blumgart LH. Central hepatic resection for pediatric tumors. J Pediatr 2002;37:986−9.

13. Melendez JA, Arslan V, Fischer ME, et al. Perioperative outcome of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion and the risk of post-operative renal dysfunction. J Am Coll Surg 1998;187:620−5.

14. Czauderna P, Otte JB, Aronson DC, et al. Guidelines for surgical treatment of hepatoblastoma in the modern era − recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer 2005;41:1031−6.

15. Coté C, Lehrman J, Anderson B. A practice of anaesthesia for infants and children. 5th ed. Philadelphia, Elsevier/Saunders 2012.

16. Lentchener C, Ozier Y. Anaesthesia for elective liver resections: some points should be revisited. Eur J Anaesthesiol 2002;19:780−8.

17. Page A, Kooby D. Perioperative management of hepatic resection. J Gastrointest Oncol 2012;3:19−27.

18. Vauthey JN, Chaoui A, Do KA, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000;127:512−9.

19. Shoup M, Gonen M, D’Angelica M, et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 2003;7:325−30.

20. Abdalla EK, Barnett CC, Doherty D, et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002;137:675−80; discussion680−1.

21. Vorst J, Dam R, Stiphout R, et al. Virtual liver resection and volumetric analysis of the future liver remnant using open source image processing software. World J Surg 2010;34:2426−33.

22. Hansen C, Zidowitz S, Ritter F, et al. Risk maps for liver surgery. Int J Computer Assist Radiol Surg 2013;8:419−28.

23. Hansen C, Zidowitz S, Preim B, et al. Impact of model-based risk analysis for liver surgery planning. Int J Computer Assist Radiol Surg 2014;9:473−80.

24. Banz VM, Baechtold M, Weber S, et al. Computer planned, image-guided combined resection and ablation for bilobar colorectal liver metastases. World J Gastroenterol 2014;20:14992−6.

25. Austin MT, Leys CM, Feurer ID, et al. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database. J Pediatr Surg 2006;41:182−6.

26. Oliverius M, Janoušek L, Adamec M, et al. Transplantace jater u dětí redukovaným štěpem. Rozhl Chir 2010;89:411−6.

27. D’Alessandro AM, Knechtle SJ, Chin LT, et al. Liver transplantation in paediatric patients: twenty years of experience at the University of Wisconsin. Pediatr Transplant 2007;11:661−70.

28. Meyers RL, Katzenstein HM, Krailo M, et al. Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma. J Pediatr Surg 2007;42:2050−6.

29. Ortega JA, Douglass EC, Feusner JH, et al. Randomized comparison of cisplatin/ vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of paediatric hepatoblastoma: a report from the Children’s Cancer Group and the Paediatric Oncology Group. J Clin Oncol 2000;18:2665−75.

30. von Schweinitz D, Hecker H, Schmidt-von-Arndt G, et al. Prognostic factors and staging systems in childhood hepatoblastoma. Int J Cancer 1997;74:593−9.

31. Fuchs J, Cavdar S, Blumenstock G, et al. POST-TEXT III and IV hepatoblastoma: extended hepatic resection avoids liver transplantation in selected cases. Ann Surg 2016; A [ Epub ahead of print].

Labels
Surgery Orthopaedics Trauma surgery
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#